| 'Short'delay in initiation of radiotherapy may not affect the outcome of patients with GBM: A secondary analysis from the RTOG database DT Blumenthal, B Berkey, D Nelson, W Curran, S Leibel, L Souhami, ... Neuro-Oncology 8 (4), 483-483, 2006 | 1 | 2006 |
| 29 Presentation and Clinical Features of Brain Metastases DT Blumenthal, F Bokstein Principles & Practice of Neuro-Oncology: A Multidisciplinary Approach, 2010 | | 2010 |
| 2901 Phase 2 study of VB-, an anti-cancer gene therapy, as monotherapy followed by combination of VB-111 with bevacizumab, in patients with recurrent glioblastoma A Brenner, Y Cohen, J Vredenburgh, K Peters, L Nayak, D Blumenthal, ... European Journal of Cancer 3 (51), S584, 2015 | 1 | 2015 |
| 426 Neuro-Oncology Practice O Regev, V Merkin, DT Blumenthal, I Melamed, T Kaisman-Elbaz Neuro-Oncology 8 (4), 426-440, 2021 | | 2021 |
| 498O INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma D Blumenthal, IK Mellinghoff, MJ van den Bent, M Touat, K Peters, ... Annals of Oncology 34, S391, 2023 | | 2023 |
| A common sense approach to radiation treatment planning of temporal lobe GBM F Bokstein, F Kovner, Z Ram, H Templehoff, AA Kanner, DT Blumenthal, ... Journal of Clinical Oncology 25 (18_suppl), 2044-2044, 2007 | 1 | 2007 |
| A common sense approach to radiotherapy planning of glioblastoma multiforme situated in the temporal lobe F Bokstein, F Kovner, DT Blumenthal, Z Ram, H Templehoff, AA Kanner, ... International Journal of Radiation Oncology* Biology* Physics 72 (3), 900-904, 2008 | 12 | 2008 |
| A MOLECULAR PREDICTOR OF RESPONSE TO BEVACIZUMAB BASED ON ANALYSIS OF RTOG 0825, A PHASE III TRIAL COMPARING CHEMORADIATION WITH AND WITHOUT BEVACIZUMAB IN PATIENTS WITH NEWLY … E Sulman, M Won, R Ezhilarasan, P Sun, D Blumenthal, M Vogelbaum, ... NEURO-ONCOLOGY 15, 152-152, 2013 | 1 | 2013 |
| A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas … LJ Swinnen, C Rankin, H Carraway, KS Albain, JJ Townsend, GT Budd, ... Journal of Neuro-oncology 86, 353-358, 2008 | 20 | 2008 |
| A phase II study of cisplatin preceded by a 12-hour continuous infusion of concurrent hydroxyurea and cytosine arabinoside (ARA-C) for adult patients with malignant gliomas H Carraway, LJ Swinnen, C Rankin, KS Albain, J Townsend, ... NEURO-ONCOLOGY 6 (4), 372-372, 2004 | | 2004 |
| A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma … DT Blumenthal, C Rankin, KJ Stelzer, AM Spence, AE Sloan, DF Moore, ... International journal of clinical oncology 20, 650-658, 2015 | 58 | 2015 |
| A prospective, cohort study of SITOIGANAP to treat glioblastoma when given in combination with granulocyte-macrophage colony-stimulating factor/cyclophosphamide/bevacizumab … DA Bota, TH Taylor, N Lomeli, XT Kong, BD Fu, AH Schönthal, S Singer, ... Frontiers in Oncology 12, 934638, 2022 | 4 | 2022 |
| A randomized trial of bevacizumab for newly diagnosed glioblastoma MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ... New England Journal of Medicine 370 (8), 699-708, 2014 | 2977 | 2014 |
| A Randomized, Double-blind, Phase 3 Study of Vorasidenib Versus Placebo in Patients with Mutant IDH1/2 Diffuse Glioma (INDIGO): Analysis of Health-related Quality of Life … K Peters, I Mellinghoff, M Van Den Bent, D Blumenthal, M Touat, J Clarke, ... Neurology 102 (17_supplement_1), 5113, 2024 | | 2024 |
| A. 6 INDIGO: a global, randomized, double-blinded, Phase 3 study of vorasidenib versus placebo in patients with grade 2 glioma with an IDH1/2 mutation (mIDH1/2) JR Perry, IK Mellinghoff, M van den Bent, DT Blumenthal, M Touat, ... Canadian Journal of Neurological Sciences 51 (s1), S4-S4, 2024 | | 2024 |
| Abstract CT206: Concurrent Tumor Treating Fields (TTFields) and radiation therapy for newly diagnosed glioblastoma: A safety and feasibility study F Bokstein, D Blumenthal, D Limon, CB Harosh, Z Ram, R Grossman Cancer Research 80 (16_Supplement), CT206-CT206, 2020 | 1 | 2020 |
| ACTR-46. TUMOR TREATING FIELDS COMBINED WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA: FINAL RESULTS FROM A PILOT STUDY R Grossman, D Limon, F Bokstein, D Blumenthal, CB Harush, Z Ram Neuro-Oncology 21 (Suppl 6), vi23, 2019 | 1 | 2019 |
| Acute myopia and angle-closure glaucoma induced by topiramate DT Blumenthal Neurology 63 (4), 762-762, 2004 | 5 | 2004 |
| Acute type II myofiber atrophy in critical illness L Gutmann, D Blumenthal, L Gutmann, SS Schochet Neurology 46 (3), 819-821, 1996 | 113 | 1996 |
| Advanced Search Search DT Blumenthal | | |
